Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
12%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
PBE
33
HOLDINGS
24%
ALSO IN CANC
CANC
54
HOLDINGS
13%
ALSO IN PBE
SECTOR DRIFT (PBE minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
EXELIXIS INC | 2.7% | 2.8% | 2.7% |
|
AMGEN INC | 4.9% | 2.6% | 2.6% |
|
LEGEND BIOTECH CORPORATION SPONSORED ADR | 2.5% | 2.6% | 2.5% |
|
HALOZYME THERAPEUTICS INC | 2.6% | 1.7% | 1.7% |
|
GILEAD SCIENCES INC | 4.5% | 1.0% | 1.0% |
PBE Overweight Relative to CANC
|
VERTEX PHARMACEUTICALS INC | 5.0% |
|
BIOGEN IDEC INC | 4.9% |
|
ROYALTY PHARMA PLC CLASS A | 4.8% |
|
ALNYLAM PHARMACEUTICALS INC | 4.6% |
|
UNITED THERAPEUTICS CORP | 4.5% |
|
REGENERON PHARMACEUTICALS | 3.9% |
|
GILEAD SCIENCES INC | 3.5% |
|
CAREDX, INC. | 3.2% |
|
VERACYTE INC | 3.2% |
|
BIO-TECHNE CORPORATION | 3.2% |
PBE Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -6.0% |
|
ELI LILLY & CO | -5.0% |
|
COGENT BIOSCIENCES INC | -5.0% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -4.1% |
|
NOVARTIS AG | -4.1% |
|
ABBVIE INC | -3.7% |
|
MERCK & CO. INC. | -3.5% |
|
BRISTOL-MYERS SQUIBB CO | -3.4% |
|
JOHNSON & JOHNSON | -3.3% |
|
CG ONCOLOGY, INC. | -2.8% |